Received Mar 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
Nurse called to return a call from someone from Merck asking more information about a patient's AE with GARDASIL 9. She did not have a case number. During the call, the call was dropped. Call back attempted and left a message with a receptionist; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), Injection for prophylaxis (exact dose, dose number, route and site of administration, lot # and expiration date were not reported). On unknown date the patient experienced unspecified adverse event (reported as "nurse called to return a call from someone, asking more information about a patient's AE"). The outcome of adverse event was unknown. The causality between adverse event and Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) was not provided.